ML 145 structure
|
Common Name | ML 145 | ||
---|---|---|---|---|
CAS Number | 1164500-72-4 | Molecular Weight | 482.572 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C24H22N2O5S2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of ML 145ML 145 is a selective GPR35/CXCR8 antagonist with an IC50/EC50 of 20.1 nM, but not for the related GPR55 orphan receptor[1]. GPR35 is expressed by various cells of the immune system and it may has potential as a therapeutic target in inflammatory disease[2]. |
Name | 2-Hydroxy-4-[(4-{(5Z)-5-[(2E)-2-methyl-3-phenyl-2-propen-1-ylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}butanoyl)amino]benzoic acid |
---|---|
Synonym | More Synonyms |
Description | ML 145 is a selective GPR35/CXCR8 antagonist with an IC50/EC50 of 20.1 nM, but not for the related GPR55 orphan receptor[1]. GPR35 is expressed by various cells of the immune system and it may has potential as a therapeutic target in inflammatory disease[2]. |
---|---|
Related Catalog | |
Target |
CXCR8:20.1 nM (IC50) |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Molecular Formula | C24H22N2O5S2 |
Molecular Weight | 482.572 |
Exact Mass | 482.097015 |
LogP | 4.38 |
Index of Refraction | 1.719 |
2-Hydroxy-4-[(4-{(5Z)-5-[(2E)-2-methyl-3-phenyl-2-propen-1-ylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}butanoyl)amino]benzoic acid |
Benzoic acid, 2-hydroxy-4-[[4-[(5Z)-5-[(2E)-2-methyl-3-phenyl-2-propen-1-ylidene]-4-oxo-2-thioxo-3-thiazolidinyl]-1-oxobutyl]amino]- |
2-Hydroxy-4-[(4-{(5Z)-5-[(2E)-2-methyl-3-phenylprop-2-en-1-ylidene]-4-oxo-2-thioxo-1,3-thiazolidin-3-yl}butanoyl)amino]benzoic acid |